Selected article for: "additional sampling and uniform sampling"

Author: Daniel B Larremore; Bailey K Fosdick; Kate M Bubar; Sam Zhang; Stephen M Kissler; C. Jessica E. Metcalf; Caroline Buckee; Yonatan Grad
Title: Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
  • Document date: 2020_4_20
  • ID: c4cs14ja_47
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint Figure 3 : Uncertainty of overall seroprevalence estimates from convenience and formal sampling strategies. Uncertainty, represented by the width of 90% credible intervals, is presented as ± seroprevalence percentage points, based on a serological test with 93% sensitivity and 97.5% specificity ( Supplementary Fig. S2 depicts results for other sensitivity and specificity.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint Figure 3 : Uncertainty of overall seroprevalence estimates from convenience and formal sampling strategies. Uncertainty, represented by the width of 90% credible intervals, is presented as ± seroprevalence percentage points, based on a serological test with 93% sensitivity and 97.5% specificity ( Supplementary Fig. S2 depicts results for other sensitivity and specificity values). (A) Curves show the decrease in average CI widths for 15% seroprevalence, illustrating the advantages of using uniform and MDI samples over convenience samples. (B) Heatmaps show average CI widths for various total sample counts and overall seroprevalence. Convenience samples derived from newborn blood spots or U.S. blood donors improve with additional sampling but retain baseline uncertainty due to demographics not covered by the convenience sample. For the estimation of overall seroprevalence, uniform sampling is marginally superior to this example of the model and demographic informed (MDI) sampling strategy, which was designed to optimize estimation of R eff . Each point or pixel is averaged over 250 stochastic draws from the specified seroprevalence with the indicated sensitivity and specificity.

    Search related documents:
    Co phrase search for related documents
    • pixel point and specificity sensitivity: 1
    • pixel point and uniform sampling: 1
    • sample count and total sample count: 1, 2, 3, 4, 5
    • sampling strategy and serological test: 1, 2
    • sampling strategy and seroprevalence estimate: 1, 2
    • sampling strategy and specificity sensitivity: 1, 2, 3, 4
    • sampling strategy and specificity sensitivity value: 1, 2
    • sampling strategy and uniform sampling: 1, 2, 3, 4
    • serological test and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • serological test and specificity sensitivity value: 1, 2, 3, 4, 5, 6
    • serological test and uniform sampling: 1, 2
    • seroprevalence estimate and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • seroprevalence estimate and specificity sensitivity value: 1
    • seroprevalence estimate and uniform sampling: 1, 2
    • specificity sensitivity and uniform sampling: 1, 2, 3, 4